234 related articles for article (PubMed ID: 31419330)
21. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
22. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
[TBL] [Abstract][Full Text] [Related]
23. Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling.
Ni HS; Hu SQ; Chen X; Liu YF; Ni TT; Cheng L
Laryngoscope; 2019 Sep; 129(9):E318-E328. PubMed ID: 30597574
[TBL] [Abstract][Full Text] [Related]
24. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.
Sun F; Jie Q; Li Q; Wei Y; Li H; Yue X; Ma Y
J Cell Mol Med; 2022 Mar; 26(5):1629-1642. PubMed ID: 35137520
[TBL] [Abstract][Full Text] [Related]
25. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
26. UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway.
He D; Zhang S
Mol Med Rep; 2018 Jan; 17(1):549-555. PubMed ID: 29115622
[TBL] [Abstract][Full Text] [Related]
27. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.
Farsam V; Basu A; Gatzka M; Treiber N; Schneider LA; Mulaw MA; Lucas T; Kochanek S; Dummer R; Levesque MP; Wlaschek M; Scharffetter-Kochanek K
Oncotarget; 2016 Dec; 7(50):83554-83569. PubMed ID: 27907906
[TBL] [Abstract][Full Text] [Related]
28. E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling Pathway.
Huang J; Zhao Y
Reprod Sci; 2023 Apr; 30(4):1229-1240. PubMed ID: 35849266
[TBL] [Abstract][Full Text] [Related]
29. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
Zhang X; Wu J; Luo S; Lechler T; Zhang JY
Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
[TBL] [Abstract][Full Text] [Related]
30. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
Wang J; Li C; Xu L; Yang C; Zhang X
Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
[TBL] [Abstract][Full Text] [Related]
31. PRR14 acts a novel oncogene activating the PI3K signal pathway in human cutaneous squamous cell carcinoma.
Zhang L; Yang J; Ji Z; Zhang J; Yang S
J Cancer; 2023; 14(9):1531-1540. PubMed ID: 37325059
[TBL] [Abstract][Full Text] [Related]
32. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-451a prevents cutaneous squamous cell carcinoma progression via the 3-phosphoinositide-dependent protein kinase-1-mediated PI3K/AKT signaling pathway.
Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
Exp Ther Med; 2021 Feb; 21(2):116. PubMed ID: 33335579
[TBL] [Abstract][Full Text] [Related]
35. Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma.
Chen S; Chen H; Wang X; Zhang D; Zhang L; Cheng J; Zhang Q; Hua Z; Miao X; Shi J
An Bras Dermatol; 2024; 99(4):535-545. PubMed ID: 38548549
[TBL] [Abstract][Full Text] [Related]
36. MiR-122 exerts anti-proliferative and apoptotic effects on nasopharyngeal carcinoma cells via the PI3K/AKT signaling pathway.
Cheng C; Xiaohua W; Ning J; Dan Z; Chengyun Y; Lijun Z; Li Y; Shengfu H; Hong J; He X
Cell Mol Biol (Noisy-le-grand); 2018 Oct; 64(13):21-25. PubMed ID: 30403591
[TBL] [Abstract][Full Text] [Related]
37. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
[TBL] [Abstract][Full Text] [Related]
38. Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis.
Ye B; Jiang LL; Xu HT; Zhou DW; Li ZS
Int J Immunopathol Pharmacol; 2012; 25(3):627-36. PubMed ID: 23058013
[TBL] [Abstract][Full Text] [Related]
39. Long Noncoding RNA LINC003121 Inhibits Proliferation and Invasion of Thyroid Cancer Cells by Suppression of the Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Pathway.
Min X; Liu K; Zhu H; Zhang J
Med Sci Monit; 2018 Jul; 24():4592-4601. PubMed ID: 29969438
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
